HP 293 (Lithium Carbonate Extended-Release 300 mg)
Pill with imprint HP 293 is Beige, Round and has been identified as Lithium Carbonate Extended-Release 300 mg. It is supplied by Heritage Pharmaceuticals Inc.
Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HP 293
Lithium Carbonate Extended-Release
- Imprint
- HP 293
- Strength
- 300 mg
- Color
- Beige
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Heritage Pharmaceuticals Inc.
- National Drug Code (NDC)
- 23155-0293
- Inactive Ingredients
-
calcium stearate,
FD&C Blue No. 2,
FD&C Yellow No. 6,
hypromelloses,
polydextrose,
polyethylene glycol,
povidone,
sodium chloride,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
sorbitol,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about lithium
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (438)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: antimanic agents
Patient resources
- Drug Information
- Lithium (Advanced Reading)
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
- Other brands
- Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.